These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 18064333)

  • 21. Long-term clinical outcome after intramuscular transplantation of granulocyte colony stimulating factor-mobilized CD34 positive cells in patients with critical limb ischemia.
    Kinoshita M; Fujita Y; Katayama M; Baba R; Shibakawa M; Yoshikawa K; Katakami N; Furukawa Y; Tsukie T; Nagano T; Kurimoto Y; Yamasaki K; Handa N; Okada Y; Kuronaka K; Nagata Y; Matsubara Y; Fukushima M; Asahara T; Kawamoto A
    Atherosclerosis; 2012 Oct; 224(2):440-5. PubMed ID: 22877866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes.
    Huang P; Li S; Han M; Xiao Z; Yang R; Han ZC
    Diabetes Care; 2005 Sep; 28(9):2155-60. PubMed ID: 16123483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Local intramuscular transplantation of autologous mononuclear cells for critical lower limb ischaemia.
    Moazzami K; Moazzami B; Roohi A; Nedjat S; Dolmatova E
    Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD008347. PubMed ID: 25525690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autologous bone-marrow mononuclear cell implantation in patients with severe lower limb ischaemia: a comparison of using blood cell separator and Ficoll density gradient centrifugation.
    Hernández P; Cortina L; Artaza H; Pol N; Lam RM; Dorticós E; Macías C; Hernández C; del Valle L; Blanco A; Martínez A; Díaz F
    Atherosclerosis; 2007 Oct; 194(2):e52-6. PubMed ID: 16982058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autologous peripheral blood CD133+ cell implantation for limb salvage in patients with critical limb ischemia.
    Burt RK; Testori A; Oyama Y; Rodriguez HE; Yaung K; Villa M; Bucha JM; Milanetti F; Sheehan J; Rajamannan N; Pearce WH
    Bone Marrow Transplant; 2010 Jan; 45(1):111-6. PubMed ID: 19448678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and efficacy of therapeutic angiogenesis as a novel treatment in patients with critical limb ischemia.
    Lara-Hernandez R; Lozano-Vilardell P; Blanes P; Torreguitart-Mirada N; Galmés A; Besalduch J
    Ann Vasc Surg; 2010 Feb; 24(2):287-94. PubMed ID: 20142004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-Term Clinical Outcomes of Autologous Bone Marrow Mononuclear Cell Implantation in Patients With Severe Thromboangiitis Obliterans.
    Mohamad Yusoff F; Kajikawa M; Takaeko Y; Kishimoto S; Hashimoto H; Maruhashi T; Kihara Y; Nakashima A; Higashi Y
    Circ J; 2020 Mar; 84(4):650-655. PubMed ID: 32132348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Autologous peripheral blood stem cells transplantation in treatment of 62 cases of lower extremity ischemic disorder].
    Yang XF; Wu YX; Wang HM; Xu YF; Lü X; Zhang YB; Wang F; Zhang Y
    Zhonghua Nei Ke Za Zhi; 2005 Feb; 44(2):95-8. PubMed ID: 15840218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autologous transplantation of bone marrow mononuclear cells for limb ischemia in a caucasian population with atherosclerosis obliterans.
    De Vriese AS; Billiet J; Van Droogenbroeck J; Ghekiere J; De Letter JA
    J Intern Med; 2008 Apr; 263(4):395-403. PubMed ID: 18221334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical application of bone marrow implantation in patients with arteriosclerosis obliterans, and the association between efficacy and the number of implanted bone marrow cells.
    Saigawa T; Kato K; Ozawa T; Toba K; Makiyama Y; Minagawa S; Hashimoto S; Furukawa T; Nakamura Y; Hanawa H; Kodama M; Yoshimura N; Fujiwara H; Namura O; Sogawa M; Hayashi J; Aizawa Y
    Circ J; 2004 Dec; 68(12):1189-93. PubMed ID: 15564705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Autologous transplantation of peripheral blood stem cell in treatment of critical limb ischemia].
    Zhang HK; Li M; Feng H
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2007 Jul; 36(4):360-3. PubMed ID: 17717827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autologous bone marrow mononuclear cell implantation therapy is an effective limb salvage strategy for patients with severe peripheral arterial disease.
    Franz RW; Shah KJ; Pin RH; Hankins T; Hartman JF; Wright ML
    J Vasc Surg; 2015 Sep; 62(3):673-80. PubMed ID: 26304481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Limited value of digital subtraction angiography in the evaluation of cell-based therapy in patients with limb ischemia.
    van Tongeren RB; Hamming JF; le Cessie S; van Erkel AR; van Bockel JH
    Int J Cardiovasc Imaging; 2010 Jan; 26(1):19-25. PubMed ID: 19757148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Both autologous bone marrow mononuclear cell and peripheral blood progenitor cell therapies similarly improve ischaemia in patients with diabetic foot in comparison with control treatment.
    Dubsky M; Jirkovska A; Bem R; Fejfarova V; Pagacova L; Sixta B; Varga M; Langkramer S; Sykova E; Jude EB
    Diabetes Metab Res Rev; 2013 Jul; 29(5):369-76. PubMed ID: 23390092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beneficial effects of autologous bone marrow cell infusion and antioxidants/L-arginine in patients with chronic critical limb ischemia.
    Napoli C; Farzati B; Sica V; Iannuzzi E; Coppola G; Silvestroni A; Balestrieri ML; Florio A; Matarazzo A
    Eur J Cardiovasc Prev Rehabil; 2008 Dec; 15(6):709-18. PubMed ID: 19050436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Local intramuscular transplantation of autologous mononuclear cells for critical lower limb ischaemia.
    Moazzami K; Majdzadeh R; Nedjat S
    Cochrane Database Syst Rev; 2011 Dec; (12):CD008347. PubMed ID: 22161427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Timing of gangrene tissue debridement after autologous bone marrow cell implantation in patients with superficial femoral arterial occlusion: preliminary experiences.
    Wang CH; Lan YJ; Yeh CH; Ng YT; Chung PV; Hsu CM; Kuo LT; Huang RE; Liu MH; Cherng WJ
    J Cardiovasc Surg (Torino); 2012 Aug; 53(4):507-16. PubMed ID: 22071470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutical potential of autologous peripheral blood mononuclear cell transplantation in patients with type 2 diabetic critical limb ischemia.
    Ozturk A; Kucukardali Y; Tangi F; Erikci A; Uzun G; Bashekim C; Sen H; Terekeci H; Narin Y; Ozyurt M; Ozkan S; Sayan O; Rodop O; Nalbant S; Sıldıroglu O; Yalnız FF; Senkal IV; Sabuncu H; Oktenli C
    J Diabetes Complications; 2012; 26(1):29-33. PubMed ID: 22240264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peripheral blood mononuclear cell transplantation to treat no-option critical limb ischaemia: effectiveness and safety.
    Sermsathanasawadi N; Pruekprasert K; Chruewkamlow N; Kittisares K; Warinpong T; Chinsakchai K; Wongwanit C; Ruangsetakit C; Mutirangura P
    J Wound Care; 2021 Jul; 30(7):562-567. PubMed ID: 34256601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic Efficacy of Autologous Non-Mobilized Enriched Circulating Endothelial Progenitors in Patients With Critical Limb Ischemia　- The SCELTA Trial.
    Liotta F; Annunziato F; Castellani S; Boddi M; Alterini B; Castellini G; Mazzanti B; Cosmi L; Acquafresca M; Bartalesi F; Dilaghi B; Dorigo W; Graziani G; Bartolozzi B; Bellandi G; Carli G; Bartoloni A; Fargion A; Fassio F; Fontanari P; Landini G; Lucente EAM; Michelagnoli S; Orsi Battaglini C; Panigada G; Pigozzi C; Querci V; Santarlasci V; Parronchi P; Troisi N; Baggiore C; Romagnani P; Mannucci E; Saccardi R; Pratesi C; Gensini G; Romagnani S; Maggi E
    Circ J; 2018 May; 82(6):1688-1698. PubMed ID: 29576595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.